Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | KIF11 | P52732 | 9/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL136229 | 1.00 | CA4 (0.54) | CA4LTA4HKIF11KCNH2CA12 | |
| SCHEMBL430047 | 0.91 | CA1 (0.58) | CA4LTA4HCA12CA1CA2 | |
| SCHEMBL774134 | 0.87 | CA4 (0.54) | CA4LTA4HKIF11KCNH2CA12 | |
| SCHEMBL8784660 | 0.87 | CA4 (0.54) | CA4LTA4HKIF11KCNH2CA12 | |
| Bromide SCHEMBL31164184 | 0.85 | CA4 (0.52) | CA4LTA4HKIF11KCNH2CA12 | |
| Hydrochloric Acid SCHEMBL30389842 | 0.85 | CA4 (0.52) | CA4LTA4HKIF11KCNH2CA12 | |
| SCHEMBL8728589 | 0.83 | KIF11 (0.56) | CA4LTA4HKIF11KCNH2CA12 | |
| SCHEMBL3932304 | 0.83 | CA4 (0.50) | CA4LTA4HKIF11KCNH2CA12 | |
| SCHEMBL21738735 | 0.83 | KIF11 (0.56) | CA4LTA4HKIF11KCNH2CA12 | |
| SCHEMBL19620174 | 0.83 | CA4 (0.50) | CA4LTA4HKIF11KCNH2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250236633-A1 | SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES | Roche Sequencing Solutions, Inc. (US) | 2025-07-24 | — | — | US | claimed |
| EP-4499655-A1 | SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES | F. Hoffmann-La Roche AG (CH) | 2025-02-05 | — | — | EP | claimed |
| WO-2023186842-A1 | SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES | F. HOFFMANN-LA ROCHE AG (CH) | 2023-10-05 | — | — | WO | claimed |
| US-20180030065-A1 | FLUORESCEIN POLYMER CONJUGATES | ISI LIFE SCIENCES, INC. (US) | 2018-02-01 | — | — | US | claimed |
| EP-3250197-A1 | FLUORESCEIN POLYMER CONJUGATES | Indicator Systems International, Inc. (US) | 2017-12-06 | — | — | EP | claimed |
| WO-2016123244-A1 | FLUORESCEIN POLYMER CONJUGATES | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2016-08-04 | — | — | WO | claimed |
| WO-2015053980-A1 | PREPARATION OF ORGANOPHOSPHATE PEPTIDE ADDUCTS | BATTELLE MEMORIAL INSTITUTE (US) | 2015-04-16 | — | — | WO | claimed |
| US-20150099864-A1 | PREPARATION OF ORGANOPHOSPHATE PEPTIDE ADDUCTS | BATTELLE MEMORIAL INSTITUTE | 2015-04-09 | — | — | US | claimed |
| WO-2008013427-A1 | ORGANIC TFTS AND METHOD FOR FABRICATING THE SAME | LG CHEM, LTD. (KR) | 2008-01-31 | — | — | WO | claimed |
| JP-2006516295-A | — | — | 2006-06-29 | — | — | JP | claimed |
| CN-1744918-A | Polymeric reagents comprising a ketone or a related functional group | NEKTAR THERAPEUTICS AL CORP (US) | 2006-03-08 | — | — | CN | claimed |
| EP-1581260-A2 | POLYMERIC REAGENTS COMPRISING A KETONE OR A RELATED FUNCTIONAL GROUP | Nektar Therapeutics Al, Corporation (US) | 2005-10-05 | — | — | EP | claimed |
| WO-2005058246-A2 | METHOD FOR PREPARING RADIOLABELED THYMIDINE | MOLECULAR TECHNOLOGIES, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| US-20050131224-A1 | Method for preparing radiolabeled thymidine | CTI PET SYSTEMS, INC. | 2005-06-16 | — | — | US | claimed |
| WO-2004060406-A2 | POLYMERIC REAGENTS COMPRISING A KETONE OR A RELATED FUNCTIONAL GROUP | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2004-07-22 | — | — | WO | claimed |
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2026-02-17 | — | — | US | disclosed |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2025-11-25 | — | — | US | disclosed |
| EP-0016157-A4 | 7-0-(2,6-DIDEOXY-ALPHA-L-LYXO-HEXOPYRANOSYL)-DESMETHOXY-ADRIAMYCINONE. | US COMMERCE (US) | 1980-11-14 | — | — | EP | disclosed |
| EP-0016157-A1 | 7-0-(2,6-DIDEOXY-ALPHA-L-LYXO-HEXOPYRANOSYL)-DESMETHOXY-ADRIAMYCINONE | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1980-10-01 | — | — | EP | disclosed |
| WO-1980000305-A1 | 7-0-(2,6-DIDEOXY-A-L-LYXO-HEXOPYRANOSYL)-DESMETHOXYDAUNOMYCINONE,ADRIAMYCINONE,AND CARMINOMYCINONE | US COMMERCE (US) | 1980-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | FCGR2A, FCGR3B, FCGR1A | CA4 192/4885LTA4H 2881/4885KIF11 3985/4885 |
| US-20180030065-A1 | FLUORESCEIN POLYMER CONJUGATES | PFAS, CD44, FGB | CA4 519/4885LTA4H 1504/4885KIF11 266/4885 |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | CA4 73/4885LTA4H 393/4885KIF11 3251/4885 |
| US-20050131224-A1 | Method for preparing radiolabeled thymidine | TYMP, TYMS, DUT | CA4 3875/4885LTA4H 1482/4885KIF11 650/4885 |
| US-20250236633-A1 | SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES | PARG, PPA1, PGM2 | CA4 1762/4885LTA4H 3409/4885KIF11 2422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.